Part of the HCPlive Healthcare Professionals Network

archives





ADVERTISEMENT

New Media Medicine - Medical Forums:
MCAT
USMLE
Residency
PLAB
UKCAT
MRCP
UMAT
GAMSAT
US Medical Schools
Canadian Medical Schools

Syndication our news feed

Medgadget by Email

Delivered by FeedBurner

Mailing List

Privacy: Your email address will be used by Medgadget editorial team only. We hate spam too.



We comply with the HONcode standard for trustworthy health
information:
verify here.



Friday, March 17, 2006

PFX™ Closure System

Filed under: Cardiology

The first winner from Frost & Sullivan's awards we would like to mention is Cierra, Inc., from Redwood City, CA. This company has been named the recipient of Frost & Sullivan's 2006 Excellence in Research of the Year Award in the field of interventional cardiology "for its outstanding research and development efforts that led to the introduction of the PFX™ Closure System."

The PFX™ Closure System is an angiographically delivered catheter that closes the patent foramen ovale (PFO)--a small opening between right and left atria of the heart, the most common congenital heart defect--without leaving behind an implant. The system achieves the closure by applying radio-frequency energy to a floppy valve of PFO. Wired News has recently profiled this company in an informative article.

Info about the PFO (the floppy valve and more)...

The press release...

email this article to a friend      print this!           comments and peer reviews (0)




replies: 0 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.